Cancer Screening for All Through the Power of Tears

Our name, Namida, is derived from the Japanese word for tears, reflecting our focus on utilizing the power of tears to identify early-stage cancers. We use cutting-edge proteomics and …

A clinical tear-based biological breast cancer screening for providers. Melody requires no specialized equipment or personnel, making it ideally suited for any walk-in diagnostic clinic. …

Jan 21, 2022 · Namida Lab Inc. is an Arkansas-based biotech company specializing in biomarker-based testing to improve diagnostic testing and patient outcomes. Namida’s first product, …

Oct 31, 2023 · Let’s disrupt. We’re a revenue stage biotech company with big ideas, and the science to make them happen. Be a part of the future of cancer screening. Subscribe to our …

Pioneering Proteomics Our research laboratory uses proteomics to develop innovative cancer screening tools. Proteomics is the study of proteins, which are essential for the functioning of …

Namida was founded in 2019 and has assembled a talented team with experience across diagnostic, medical information, and scientific automation fields to develop a diagnostic …

Namida is monitored periodically by CMS through proficiency testing (PT). Since our test utilizes a “non-regulated” analyte, we designed our proficiency testing protocol using Federal (CLIA) …

Namida Lab and CARTI Partner to Study Proteins in Cancer Patients’ Tears Press Release December 17, 2021

Jun 12, 2022 · Northwest Arkansas-based Namida Lab is conducting a clinical research study designed for women with dense breast tissue to evaluate the performance of Melody®, a tear …